Rock Springs Capital Management’s Dare Bioscience DARE Stock Holding History

Rock Springs Capital Management’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,208	Closed	-$135K	–	151
2017 Q4	$135K	Hold	5,208	–	–	0.01%	145
2017 Q3	$195K	Hold	5,208	–	–	0.01%	146
2017 Q2	$276K	Hold	5,208	–	–	0.01%	148
2017 Q1	$508K	Hold	5,208	–	–	0.03%	139
2016 Q4	$443K	Hold	5,208	–	–	0.03%	130
2016 Q3	$654K	Hold	5,208	–	–	0.04%	134
2016 Q2	$1.32M	Hold	5,208	–	–	0.1%	128
2016 Q1	$1.69M	Hold	5,208	–	–	0.14%	117
2015 Q4	$1.75M	Hold	5,208	–	–	0.13%	112
2015 Q3	$2.29M	Hold	5,208	–	–	0.19%	108
2015 Q2	$2.88M	Buy	5,208 +708	+16%	+$486K	0.21%	105
2015 Q1	$4.87M	Sell	4,500 -83	-2%	-$80.3K	0.46%	72
2014 Q4	$3.42M	Buy	4,583 +3,869	+542%	+$2.41M	0.4%	76
2014 Q3	$361K	Hold	714	–	–	0.06%	82
2014 Q2	$497K	Buy	+714	New	+$551K	0.09%	78

Other funds holding DARE

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Rock Springs Capital Management's DARE Position: Q1 2018 in Review

Rock Springs Capital Management sold out of Dare Bioscience (DARE) in Q1 2018, closing a stake of 5,208 shares — an estimated $135K sold.

Rock Springs Capital Management first reported a position in DARE in Q2 2014 and held it in 15 quarters. The position peaked at $4.87M in Q1 2015. 15 funds tracked by Wall St. Rank hold DARE as of Q1 2018.

Rock Springs Capital Management reported no remaining Dare Bioscience position as of Q1 2018 after selling out during the quarter.
Rock Springs Capital Management sold 5,208 Dare Bioscience shares in Q1 2018, an estimated $135K.
Rock Springs Capital Management first reported a position in Dare Bioscience in Q2 2014 and held it in 15 quarters.
Rock Springs Capital Management's Dare Bioscience position peaked at $4.87M in Q1 2015.
15 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2018.

Based on Rock Springs Capital Management's 13F filing for Q1 2018, filed 15 May 2018.